Twist Bioscience Corp (TWST)
16.52
+0.01 (+0.06%)
USD |
NASDAQ |
Mar 20, 16:00
16.52
0.00 (0.00%)
After-Hours: 20:00
Twist Bioscience Cash from Operations (TTM): -131.80M for Dec. 31, 2022
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2022 | -131.80M |
September 30, 2022 | -124.38M |
June 30, 2022 | -157.92M |
March 31, 2022 | -151.76M |
December 31, 2021 | -133.96M |
September 30, 2021 | -112.24M |
June 30, 2021 | -102.64M |
March 31, 2021 | -98.15M |
December 31, 2020 | -132.27M |
Date | Value |
---|---|
September 30, 2020 | -142.26M |
June 30, 2020 | -140.41M |
March 31, 2020 | -139.02M |
December 31, 2019 | -101.17M |
September 30, 2019 | -87.94M |
June 30, 2019 | -81.28M |
March 31, 2019 | -76.14M |
December 31, 2018 | -71.83M |
September 30, 2018 | -66.16M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-157.92M
Minimum
Jun 2022
-66.16M
Maximum
Sep 2018
-113.96M
Average
-118.31M
Median
Cash from Operations (TTM) Benchmarks
Perspective Therapeutics Inc | -7.389M |
Xtant Medical Holdings Inc | -5.341M |
Asensus Surgical Inc | -58.94M |
Ra Medical Systems Inc | -25.25M |
Retractable Technologies Inc | 21.25M |